Clinical Trials Directory

Trials / Completed

CompletedNCT02776540

Clopidogrel for Acute Ischaemia of Recent Onset

Clopidogrel Loading for Acute Ischaemia of Recent Onset (CAIRO)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
188 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Evaluate the role of loading Clopidogrel in acute ischemic stroke in improving neurological outcome of stroke in cases patients will be non-eligible for, or declined, treatment with or intravenous thrombolysis with rTPA, rTPA is not available or thrombectomy.

Conditions

Interventions

TypeNameDescription
DRUGClopidogrelthere is 2 groups one group will receive 900 mg Clopidogrel and the other will receive 600 mg Clopidogrel
DRUGAspirinthere's another group will receive 400 mg Aspirin

Timeline

Start date
2016-06-01
Primary completion
2019-02-01
Completion
2019-02-01
First posted
2016-05-18
Last updated
2019-02-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02776540. Inclusion in this directory is not an endorsement.